OliX Pharmaceuticals, Inc (KOSDAQ:226950)
172,500
-12,100 (-6.55%)
Apr 30, 2026, 3:30 PM KST
253.12% (1Y)
| Market Cap | 3.75T +355.1% |
| Revenue (ttm) | 14.67B +158.3% |
| Net Income | -15.74B |
| EPS | -800.46 |
| Shares Out | 20.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 292,203 |
| Average Volume | 278,783 |
| Open | 182,500 |
| Previous Close | 184,600 |
| Day's Range | 171,100 - 182,500 |
| 52-Week Range | 34,500 - 217,000 |
| Beta | 0.56 |
| RSI | 48.74 |
| Earnings Date | Mar 27, 2026 |